Pages

Subscribe:

Wednesday, May 30, 2012

Sanofi, Novo, Lilly shape up for big insulin fight

LONDON (Reuters) - Competition is ramping up in the multibillion-dollar market for long-lasting insulins, with Novo Nordisk and Eli Lilly lining up new products that could trump Sanofi's top-seller Lantus.

incorporate panama

0 comments:

Post a Comment